Los Angeles, CA (January 7th, 2013)
USA Graphite Inc (OTC: USGT) increased 1.75% to $0.870 on a traded volume of 1.20 million shares. The Company informed its shareholders of its activities in selecting the location of a high-quality Canadian project for a potential acquisition. The Company has identified the West Coast of Canada as the ideal location to acquire a project that would significantly increase the Company's operations. Eagle Graphite, which is a privately held Canadian corporation, is located on the West Coast of Canada and is one of only two natural flake graphite mines operating in North America.
Will USGT Move Higher After Today’s Sudden Selling Activities? Don’t Miss The Free Trend Analysis here http://beststocksdaily.com/p2/index.php?company=USGT
AMARANTUS BIOSCI INC (OTC: AMBS) decreased 0.07% to $0.150. The stock opened at $0.16. So far this year, the stock is up over 16%. The 52-week range for the stock is $0.0 and $0.19. The organization is a development stage biotechnology company, focuses on the discovery and development of therapeutic proteins and biologics for the treatment of Parkinson disease, traumatic brain injury and other human diseases in the United States.
How Should Investors Trade AMBS After The Recent Momentum, Find Out Here http://beststocksdaily.com/p2/index.php?company=AMBS
Southridge Enterprises Inc (PINKSHEETS: SRGE) is currently trading at $0.0057. The U.S. Securities and Exchange Commission had temporarily suspended trading in the securities of Southridge because of questions regarding the accuracy of statements made by Southridge in press releases to investors concerning, among other things, the company's business operations and arrangements.
Southridge Minerals focuses on the acquisition, exploration, and development of gold and silver mines in Mexico.
Get Free Special Trend Analysis On SRGE Here http://beststocksdaily.com/p2/index.php?company=SRGE
HEAR ATLAST HOLDINGS INC (PINKSHEETS: HRAL) declined 11.76% to $0.0030. The 52-week range for the stock is $0.01 and $0.03. The Company has Price/Sales ratio of 7.65. The 50-Day Moving Average and 200-Day Moving Average prices is $0.01 and $0.01 respectively. The Company operates hearing clinics or stores that sell various hearing assessments and digital hearing aids in North America.
Get Free Special Trend Analysis On HRAL Here http://beststocksdaily.com/p2/index.php?company=HRAL
Cellceutix Corp (OTC :CTIX) is up 4.86% to $1.95. The Company provided information on the planned upcoming European clinical trials for Kevetrin. Kevetrin is the Company's flagship anti-cancer compound. The clinical phase 1b trial is named "A Multi-Center, Open-Label, Phase 1b Study of Kevetrin with Cytarabine in Patients with Acute Myelogenous Leukemia." The Company is a clinical stage biopharmaceutical company focused on discovering small molecule drugs to treat unmet medical conditions, including drug-resistant cancers and autoimmune diseases.
Get Free Special Trend Analysis On CTIX Here http://beststocksdaily.com/p2/index.php?company=CTIX
Beststocksdaily’s team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdaily’s instant stock news on Major Gainers, Hot Stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at Beststocksdaily.com.
The assembled information disseminated by beststocksdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. beststocksdaily.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
1419 WESTWOOD BLVD LOS ANGELES, CA